Evidence map›Paper›PMID 38277617›Full record

ArticleJCO oncology practice2024

Once Upon a Time…. Simple, Sensible Management of Venous Access for Chemotherapy Delivery in Germ Cell Tumors.

Guliz Ozgun, LaTrice Haney, Sean Kern, Jennifer King, Anishka D'Souza, Torgrim Tandstad, Lucia Nappi, Christian Kollmannsberger, Craig R Nichols

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in JCO oncology practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Guliz OzgunBritish Columbia Cancer, Department of Medical Oncology, Vancouver, British Columbia, Canada.ORCID 0000-0002-9575-8214
LaTrice HaneyIndiana University Medical Center, Division of Hematology/Oncology, Indianapolis, IN.
Sean KernUniformed Services University, Murtha Cancer Center, Department of Surgery, Bethesda, MD.ORCID 0000-0001-8753-5726
Jennifer KingIndiana University Medical Center, Division of Hematology/Oncology, Indianapolis, IN.ORCID 0000-0003-3413-451X
Anishka D'SouzaKeck Cancer Center, Division of Hematology Oncology, University of Southern California, Los Angeles, CA.
Torgrim TandstadDepartment of Clinical and Molecular Medicine, The Norwegian University of Science and Technology, Trondheim, Norway.
Lucia NappiBritish Columbia Cancer, Department of Medical Oncology, Vancouver, British Columbia, Canada.ORCID 0000-0002-4365-7251
Christian KollmannsbergerBritish Columbia Cancer, Department of Medical Oncology, Vancouver, British Columbia, Canada.ORCID 0000-0002-6329-761X
Craig R NicholsTesticular Cancer Commons, Portland, OR.ORCID 0000-0002-6256-1511
BC Cancer Agency · CAUniversity Medical Center · USNorwegian University of Science and Technology · NOTesticular Cancer Commons · USUniformed Services University of the Health Sciences · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Neoplasms, Germ Cell and EmbryonalAntineoplastic Combined Chemotherapy ProtocolsHumans

Identifiers

PMID38277617
OpenAlexW4391247538

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.